Franjic D, Fountaine RJ, Nalpas C, Goswami B, et al. Efficacy and safety of rimegepant 75 mg orally disintegrating tablet for the acute treatment of chronic rhinosinusitis in adults: Results from a multicenter, randomized, placebo-controlled, phase 2/3 trial. PLoS One 2026;21:e0342907.
PMID: 41779821